Other studies of patients with hyperinsulinaemia conditions, such as in CVD and chronic kidney disease, have detected vascular smooth muscle cell osteogenic differentiation and aortic valve tissue having an increased expression of sclerostin [39,47,48,49,50], corroborating the relationship between chronic increased insulin exposure altering gene expression in the osteogenic profile. The gene discussed is SOST; the disease is chronic kidney disease.